目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product
Market segments
Comparison by Product
Growth hormone - Market size and forecast 2020-2025
Diabetes - Market size and forecast 2020-2025
Fertility - Market size and forecast 2020-2025
Osteoporosis - Market size and forecast 2020-2025
Others - Market size and forecast 2020-2025
Market opportunity by Product

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
AstraZeneca Plc
Becton Dickinson and Co.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Merck KGaA
Novartis AG
Novo Nordisk AS
Owen Mumford Ltd.
Sanofi SA
Ypsomed Holding AG

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ billion)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Product - Market share 2020-2025 (%)
22: Comparison by Product
23: Growth hormone - Market size and forecast 2020-2025 ($ billion)
24: Growth hormone - Year-over-year growth 2020-2025 (%)
25: Diabetes - Market size and forecast 2020-2025 ($ billion)
26: Diabetes - Year-over-year growth 2020-2025 (%)
27: Fertility - Market size and forecast 2020-2025 ($ billion)
28: Fertility - Year-over-year growth 2020-2025 (%)
29: Osteoporosis - Market size and forecast 2020-2025 ($ billion)
30: Osteoporosis - Year-over-year growth 2020-2025 (%)
31: Others - Market size and forecast 2020-2025 ($ billion)
32: Others - Year-over-year growth 2020-2025 (%)
33: Market opportunity by Product
34: Customer landscape
35: Market share By Geographical Landscape 2020-2025 (%)
36: Geographic comparison
37: North America - Market size and forecast 2020-2025 ($ billion)
38: North America - Year-over-year growth 2020-2025 (%)
39: Europe - Market size and forecast 2020-2025 ($ billion)
40: Europe - Year-over-year growth 2020-2025 (%)
41: Asia - Market size and forecast 2020-2025 ($ billion)
42: Asia - Year-over-year growth 2020-2025 (%)
43: ROW - Market size and forecast 2020-2025 ($ billion)
44: ROW - Year-over-year growth 2020-2025 (%)
45: Key leading countries
46: Market opportunity By Geographical Landscape ($ billion)
47: Impact of drivers and challenges
48: Vendor landscape
49: Landscape disruption
50: Industry risks
51: Vendors covered
52: Market positioning of vendors
53: AstraZeneca Plc - Overview
54: AstraZeneca Plc - Product and service
55: AstraZeneca Plc - Key offerings
56: AstraZeneca Plc - Key customers
57: AstraZeneca Plc - Segment focus
58: Becton Dickinson and Co. - Overview
59: Becton Dickinson and Co. - Business segments
60: Becton Dickinson and Co. - Key offerings
61: Becton Dickinson and Co. - Key customers
62: Becton Dickinson and Co. - Segment focus
63: Eli Lilly and Co. - Overview
64: Eli Lilly and Co. - Business segments
65: Eli Lilly and Co. - Key offerings
66: Eli Lilly and Co. - Key customers
67: Eli Lilly and Co. - Segment focus
68: F. Hoffmann-La Roche Ltd. - Overview
69: F. Hoffmann-La Roche Ltd. - Business segments
70: F. Hoffmann-La Roche Ltd. - Key offerings
71: F. Hoffmann-La Roche Ltd. - Key customers
72: F. Hoffmann-La Roche Ltd. - Segment focus
73: Merck KGaA - Overview
74: Merck KGaA - Business segments
75: Merck KGaA - Key offerings
76: Merck KGaA - Key customers
77: Merck KGaA - Segment focus
78: Novartis AG - Overview
79: Novartis AG - Business segments
80: Novartis AG - Key offerings
81: Novartis AG - Key customers
82: Novartis AG - Segment focus
83: Novo Nordisk AS - Overview
84: Novo Nordisk AS - Business segments
85: Novo Nordisk AS - Key offerings
86: Novo Nordisk AS - Key customers
87: Novo Nordisk AS - Segment focus
88: Owen Mumford Ltd. - Overview
89: Owen Mumford Ltd. - Product and service
90: Owen Mumford Ltd. - Key offerings
91: Owen Mumford Ltd. - Key customers
92: Owen Mumford Ltd. - Segment focus
93: Sanofi SA - Overview
94: Sanofi SA - Business segments
95: Sanofi SA - Key offerings
96: Sanofi SA - Key customers
97: Sanofi SA - Segment focus
98: Ypsomed Holding AG - Overview
99: Ypsomed Holding AG - Business segments
100: Ypsomed Holding AG - Key offerings
101: Ypsomed Holding AG - Key customers
102: Ypsomed Holding AG - Segment focus
103: Currency conversion rates for US$
104: Research Methodology
105: Validation techniques employed for market sizing
106: Information sources
107: List of abbreviations